H&T Presspart is pleased to announce it has become a member of the Drug, Chemical & Associated Technologies Association (DCAT), an organization renowned for fostering a dynamic network within the life sciences and pharmaceutical industries.

By joining DCAT, H&T Presspart is taking a strategic step on its journey to become a market leader in the design development and manufacture of drug delivery devices.  DCAT will allow H&T Presspart to engage with decision-makers across the global pharmaceutical, and biotechnology sectors, facilitating partnerships and fostering a collaborative approach to address the industry’s most pressing challenges in drug delivery.

Julian Hemy, H&T Presspart’s Vice President- Commercial, commented “We are extremely pleased to join DCAT, and this membership underscores our commitment to advancing our position within the global pharmaceutical supply chain for medical devices.”

DCAT’s industry-focused programs and events provide unique opportunities for members to gain in-depth market intelligence, explore potential partnerships, and engage in thought leadership. As a new member, H&T Presspart is excited to leverage these resources to enhance its services to customers and contribute to the broader pharmaceutical community.

H&T Presspart looks forward to participating in DCAT Week, the premier global event in March 2025, where members gather to discuss trends, challenges, and emerging opportunities in the life sciences supply chain.